Market Research Logo

Canada Pharmaceuticals and Healthcare Report Q2 2015

Canada Pharmaceuticals and Healthcare Report Q2 2015

BMI View: Supported by strong democratic institutions and a long history of stable political Leadership,Canada is home to the second largest pharmaceutical market in the Americas and one of the largest inworld. We believe that drugmakers will continue to realise considerable rewards, as sales of patentedpharmaceuticals settle into a trend of steady growth, which is only nominally affected by the particularlyslow penetration of generics. However, drugmakers will find their interests threatened by the potential for asharp correction in private consumption which has been made increasingly fragile by high household debt,a weaker Canadian dollar and expectations of tightening of credit conditions once the Bank of Canadabegins to raise interest rates.

Headline Expenditure Projections

Pharmaceuticals: CAD22.93bn (USD20.75bn) in 2014 to CAD23.62bn (USD19.68bn) in 2015; +3.0%in local currency terms and -5.2% in US dollar terms. Forecast revised upwards from Q115.

Healthcare: CAD211.92bn (USD191.85bn) in 2014 to CAD220.60bn (USD183.84bn) in 2015; +4.1% inlocal currency terms and -4.2% in US dollar terms. Forecast revised downwards from Q115.


BMI Industry View
SWOT
Political
Economic
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Canada 2011-2019)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data and Forecasts (Canada 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data and Forecasts (Canada 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data and Forecasts (Canada 2011-2019)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data and Forecasts (Canada 2011-2019)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Canada 2011-2019)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data and Forecasts (Canada 2011-2019)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Canada 2011-2019)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Canada 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Canada 2013-2019)
Key Risks To BMI's Forecast Scenario
Macroeconomic Forecasts
Economic Analysis
Table: Canada - Economic Growth Forecasts
Industry Risk Reward Ratings
Americas Risk/Reward Index
Canada Risk/Reward Index
Rewards
Risks
Market Overview
Industry Trends And Developments
Epidemiology
Healthcare Sector
Research & Development
Table: Healthcare Resources
Table: Healthcare Activity
Table: Healthcare Personnel
Biotechnology
Biosimilar Medicines
Personalised Medicine
Regulatory Development
Pharmacovigilance
Intellectual Property Regime
Pricing Regime
Reimbursement Regime
Competitive Landscape
Pharmaceutical Industry
Pharmaceutical Re-import Policy
Pharmaceutical Retail
Company Profile
Pfizer
GlaxoSmithKline
Novartis
Sanofi
Merck
Apotex
Valeant
Demographic Forecast
Table: Population Headline Indicators (Canada 1990-2025)
Table: Key Population Ratios (Canada 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Canada 1990-2025)
Table: Population By Age Group (Canada 1990-2025)
Table: Population By Age Group % (Canada 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report